A study to analyse the effectiveness of the medications named magnesium and lignocaine in pain control after back surgeries
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2019/01/017195
- Lead Sponsor
- MIOT Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.American society of anesthesiologists physical status class I and II
2.Age between 18 to 60 years
Exclusion Criteria
1.Patients undergoing emergency surgery
2.Patients with pre-existing neurological disorders
3.Patients with liver and renal disease
4.Patients with psychiatric illness
5.Patients on antiepileptic medication
6.Patients with history of allergy to magnesium or lignocaine
7.Patients with cardiac conduction abnormality
8.Patients on chronic opioid therapy
9.Patients on calcium channel blockers
10.Patients with ASA III, IV and V status
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post operative opioid requirementTimepoint: 1, 2, 3, 4, 5, 6, 8, 10, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72 in Hours
- Secondary Outcome Measures
Name Time Method Pain score with respect to visual analogue scale (VAS)Timepoint: 1, 2, 3, 4, 5, 6, 8, 10, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72 in Hours